ATE47315T1 - Verfahren zur herstellung einer chlorierten, bromierten, radiobromierten, jodierten und/oder radiojodierten aromatischen oder heteroaromatischen verbindung, sowie ein kit zur herstellung einer auf diese verbindung gegruendete diagnostische zusammensetzung. - Google Patents

Verfahren zur herstellung einer chlorierten, bromierten, radiobromierten, jodierten und/oder radiojodierten aromatischen oder heteroaromatischen verbindung, sowie ein kit zur herstellung einer auf diese verbindung gegruendete diagnostische zusammensetzung.

Info

Publication number
ATE47315T1
ATE47315T1 AT85200798T AT85200798T ATE47315T1 AT E47315 T1 ATE47315 T1 AT E47315T1 AT 85200798 T AT85200798 T AT 85200798T AT 85200798 T AT85200798 T AT 85200798T AT E47315 T1 ATE47315 T1 AT E47315T1
Authority
AT
Austria
Prior art keywords
preparation
compound
iodinated
aromatic
brominated
Prior art date
Application number
AT85200798T
Other languages
English (en)
Inventor
John Mertens
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BE0/212997A external-priority patent/BE899739A/nl
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE47315T1 publication Critical patent/ATE47315T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
    • C07C63/70—Monocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B39/00—Halogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT85200798T 1984-05-24 1985-05-20 Verfahren zur herstellung einer chlorierten, bromierten, radiobromierten, jodierten und/oder radiojodierten aromatischen oder heteroaromatischen verbindung, sowie ein kit zur herstellung einer auf diese verbindung gegruendete diagnostische zusammensetzung. ATE47315T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE0/212997A BE899739A (nl) 1984-05-24 1984-05-24 Werkwijze voor het controleren van de substitutie op aromatische kern,en, werkwijze en apparatuur ter bereiding van samenstelling voor scintigrafisch onderzoek.
NL8402138 1984-07-05
EP85200798A EP0165630B1 (de) 1984-05-24 1985-05-20 Verfahren zur Herstellung einer chlorierten, bromierten, radiobromierten, jodierten und/oder radiojodierten aromatischen oder heteroaromatischen Verbindung, sowie ein Kit zur Herstellung einer auf diese Verbindung gegründete diagnostische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE47315T1 true ATE47315T1 (de) 1989-11-15

Family

ID=25654100

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85200798T ATE47315T1 (de) 1984-05-24 1985-05-20 Verfahren zur herstellung einer chlorierten, bromierten, radiobromierten, jodierten und/oder radiojodierten aromatischen oder heteroaromatischen verbindung, sowie ein kit zur herstellung einer auf diese verbindung gegruendete diagnostische zusammensetzung.

Country Status (6)

Country Link
US (2) US4942231A (de)
EP (1) EP0165630B1 (de)
JP (6) JPH06102079B2 (de)
AT (1) ATE47315T1 (de)
AU (1) AU576861B2 (de)
DE (1) DE3573725D1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
EP0460118A1 (de) * 1989-03-23 1991-12-11 Mallinckrodt International Corporation Radioaktive mit jod oder brom markierte piperidinverbindung sowie verfahren und zusammensetzung, die diese enthält
US5312592A (en) * 1990-06-13 1994-05-17 Scanditronix Ab Disposable kit for preparation
EP0584256B1 (de) * 1991-04-22 1999-11-10 Mallinckrodt Medical, Inc. Verbindungen und pharmazeutische zusammensetzungen zum nachweis und zur lokalisierung von geweben mit neurokinin-1-rezeptoren
DE69231469T2 (de) * 1991-08-29 2001-01-25 Mallinckrodt Medical, Inc. Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
US5750089A (en) * 1996-01-11 1998-05-12 Neuro Imaging Technologies, Llc Halogenated neuroprobe for mapping monoamine reuptake sites
US5310912A (en) * 1992-02-25 1994-05-10 Research Biochemicals Limited Partnership Iodinated neuroprobe for mapping monoamine reuptake sites
US5698179A (en) * 1992-02-25 1997-12-16 Neuro Imaging Technologies, Llc Iodinated neuroprobe for mapping monoamine reuptake sites
US5342926A (en) * 1993-06-08 1994-08-30 The Regents Of The University Of California Analogs of cytochalasin B as radiopharmaceuticals for nuclear imaging of trans-membrane glucose transport
US5529189A (en) * 1995-08-02 1996-06-25 Daxor Corporation Syringe assembly for quantitative measurement of radioactive injectate and kit having same
AU7164996A (en) * 1995-10-10 1997-04-30 Jimmie L. Johnson Constituent delivery system
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
ES2374743T3 (es) * 1995-12-01 2012-02-21 Molecular Insight Pharmaceuticals, Inc. Estereoisómeros de análogos de ácidos grasos para imagen de diagnóstico.
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
AU4068299A (en) * 1998-03-30 1999-10-18 Sloan-Kettering Institute For Cancer Research Bismuth-213 generator and uses thereof
IL142765A0 (en) * 1998-11-13 2002-03-10 Cellomics Inc Methods and system for efficient collection and storage of experimental data
US6307045B1 (en) * 1999-07-05 2001-10-23 Sumitomo Chemical Company, Limited Process for producing halogenated benzene compound
JP4161487B2 (ja) * 1999-11-01 2008-10-08 ソニー株式会社 データ復号装置及び方法
CA2396495A1 (en) 2000-01-25 2001-08-02 Cellomics, Inc. Method and system for automated inference creation of physico-chemical interaction knowledge from databases of co-occurrence data
US7514067B2 (en) * 2000-04-25 2009-04-07 President And Fellows Of Harvard College Methods for tumor diagnosis and therapy
JP4615165B2 (ja) * 2001-09-27 2011-01-19 株式会社細川洋行 液体用袋の製造方法
WO2003057214A1 (en) 2001-12-28 2003-07-17 Somatocor Pharmaceuticals, Inc. Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
EP1499584B1 (de) * 2002-04-30 2010-08-18 Emory University Verbindungen zur abbildung von tumoren
USD554764S1 (en) * 2005-03-22 2007-11-06 Gerretz Herbert A Extraction vial
USD554763S1 (en) * 2005-03-22 2007-11-06 Gerretz Herbert A Extraction vial
CA2612187C (en) * 2005-06-23 2013-05-07 Emory University Stereoselective synthesis of amino acid analogs for tumor imaging
AU2006262502A1 (en) * 2005-06-23 2007-01-04 Emory Univerisity Imaging agents
GB0514087D0 (en) * 2005-07-11 2005-08-17 Ge Healthcare Ltd Stabilised radiopharmaceutical compositions
EP1977769A1 (de) * 2007-04-04 2008-10-08 Atomic Energy Council - Institute of Nuclear Energy Research Kit zur Herstellung eines radioaktiven Iod-Markers beinhaltend lyophilisiertes Meta-Iodobenzylguanidin (MIBG), Herstellungsverfahren dafür sowie Methode zur radioaktiven markierung des MIBG.
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
US9403624B2 (en) * 2009-08-24 2016-08-02 Beekley Corporation Device and method for dispensing a beverage and imaging contrast agent
USD714644S1 (en) * 2012-09-26 2014-10-07 Target Brands, Inc. Bottle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE720365A (de) * 1967-09-11 1969-02-17
US3814769A (en) * 1969-05-01 1974-06-04 Mallinckrodt Chemical Works Catalyzed radioiodine exchange
US3859429A (en) * 1972-07-07 1975-01-07 Horst Hermann Elias M-iodohippuric acid labelled with radioactive iodine and process for its preparation
US4031198A (en) * 1972-08-30 1977-06-21 Minnesota Mining And Manufacturing Company Technetium-labeled complexes, production and use thereof
US4032625A (en) * 1973-06-11 1977-06-28 Research Corporation Bone-seeking technetium-99m complex
JPS5932457B2 (ja) * 1978-11-29 1984-08-09 エフ・ホフマン−ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 放射性ヨウ素化アミン
US4298591A (en) * 1979-04-03 1981-11-03 The United States Of America As Represented By The United States Department Of Energy Instantaneous radioiodination of rose bengal at room temperature and a cold kit therefor
EP0071858A1 (de) * 1981-08-06 1983-02-16 Miles Laboratories, Inc. Silierkonservierung mit Propionsäure erzeugenden Mikroorganismen
FR2511870A1 (fr) * 1981-08-28 1983-03-04 Guerbet Sa Procede pour augmenter la tolerance des produits opacifiants, composes utilisables a cet effet et produits opacifiants les contenant
JPS5896031A (ja) * 1981-12-03 1983-06-07 Nippon Mejifuijitsukusu Kk 放射性診断剤およびその製造用組成物
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
BE899739A (nl) * 1984-05-24 1984-11-26 Univ Bruxelles Werkwijze voor het controleren van de substitutie op aromatische kern,en, werkwijze en apparatuur ter bereiding van samenstelling voor scintigrafisch onderzoek.

Also Published As

Publication number Publication date
AU576861B2 (en) 1988-09-08
JPH06197942A (ja) 1994-07-19
JPH06102079B1 (de) 1994-12-14
AU4272785A (en) 1985-11-28
US4942231A (en) 1990-07-17
US5021220A (en) 1991-06-04
JPH06211699A (ja) 1994-08-02
EP0165630A2 (de) 1985-12-27
JPH06237999A (ja) 1994-08-30
JPH06199704A (ja) 1994-07-19
EP0165630A3 (en) 1986-01-08
JP2513573B2 (ja) 1996-07-03
DE3573725D1 (en) 1989-11-23
JPH06211700A (ja) 1994-08-02
JPH06102079B2 (ja) 1994-12-14
JPH06211698A (ja) 1994-08-02
EP0165630B1 (de) 1989-10-18

Similar Documents

Publication Publication Date Title
AU576861B2 (en) Halogenation of aromatic compounds
ATE258925T1 (de) Verfahren zur herstellung von isocyanatverbindungen aus haloaminotriazinen und säurehalogeniden
EP0707851A3 (de) Benzopyranphenol-Derivate zur Anwendung als bakterienhemmende, antivirale und immunoanregende Mittel
EP0266182A3 (de) Gamma-Lactoncarbonsäure-Derivate und ihre Herstellung
ATE60715T1 (de) Verfahren zur isolation und reinigung von mit radioaktivem rhenium verknuepften pharmaka, ihre verwendung und besteck hierfuer.
DK162045C (da) Trijodbenzenderivater, fremgangsmaade til fremstilling deraf og radiologiske praeparater indeholdende saadanne forbindelser
NZ212156A (en) Substituted imidazoles and triazoles and microbicidal compositions
ATE30426T1 (de) Peneme, sie enthaltende pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung.
ATE28636T1 (de) Pyridazinon-derivate, verfahren zu ihrer herstellung un ihre verwendung als fungizide.
KR840005139A (ko) 피라졸로피리딘 유도체의 제조방법
ES8201130A1 (es) Un metodo para preparar derivados de oxima e imina de 2-ni- tro-5-(fenoxi sustituido)-fenilalcanona
ATE32706T1 (de) Verfahren zur herstellung von 4hydroxybenzophenonen.
WO1998002443A1 (de) Verfahren zur synthese von grignard-verbindungen unter einsatz von katalysatoren
EP1008601A3 (de) Verfahren zur Herstellung ein Palladiumkomplexverbindung
EP0140437A3 (de) Substituierte Azetidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Zwischenprodukte
ATE19626T1 (de) Substituierte hydroxyalkyl-azole, verfahren zu ihrer herstellung und ihre verwendung als antimykotika.
JPH01254659A (ja) ピロール誘導体
Ballester et al. Two new inert carbon biradicals of the triphenylmethyl series. Synthesis, conformation and spin exchange
ATE90325T1 (de) Verfahren zur herstellung von aliphatischen substituierten fluorbenzolen.
NL189192B (nl) Werkwijze ter bereiding van aromatisch bis(ether-ftaalzuur) of aromatisch bis(ether-anhydride).
ATE10844T1 (de) Chinolincarbonsaeurederivat, verfahren zu seiner herstellung und es enthaltende bakterizide mittel.
ATE120752T1 (de) Verfahren zur herstellung von alpha-chlor- phosphoryliden.
ES8404310A1 (es) Diaminas aromaticas halogenadas.
DE68902000T2 (de) Verfahren zur herstellung von orthosubstituiertem monobromiertem phenolderivat.
JPS6431761A (en) Polyhalogenoindoline derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee